Switching to Reduced Oxidant or Nicotine Content Cigarettes in Smokers

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

January 1, 2017

Conditions
Tobacco Smoking Behavior
Interventions
OTHER

Reduced Nicotine Cigarettes

Human topography data will show if smokers smoke their cigarettes differently from baseline following randomization. Select biosamples of participants will be used to analyze how biomarkers differ among groups

OTHER

Reduced ROS/RNS

Human topography data will show if smokers smoke their cigarettes differently from baseline following randomization. Select biosamples of participants will be used to analyze how biomarkers differ among groups

OTHER

Control

Human topography data will show if smokers change the way they smoke due to being in a research study. Select biosamples of participants will be used to analyze how biomarkers differ among groups

Trial Locations (1)

17033

Penn State Hershey, Hershey

All Listed Sponsors
collaborator

Food and Drug Administration (FDA)

FED

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Milton S. Hershey Medical Center

OTHER

NCT02415270 - Switching to Reduced Oxidant or Nicotine Content Cigarettes in Smokers | Biotech Hunter | Biotech Hunter